[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600819":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":60,"collaborators":63,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":19,"eligibilityCriteria":74,"healthyVolunteers":71,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":19,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":90,"overallStatus":35,"whyStopped":19,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Korea University Guro Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Opioid Stewardship Program Intervention Group","EXPERIMENTAL","Participants in this arm are adult outpatients with chronic non-cancer pain who receive a pharmacist-led Opioid Stewardship Program (OSP) for their chronic opioid use.",[13],"Other: Opioid Stewardship Program",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Opioid Stewardship Program","The Opioid Stewardship Program (OSP) includes pain and functional assessments, opioid prescription review and coordination, patient education, and counseling provided by trained pharmacists.",[9],null,[21],{"name":22,"affiliation":5,"role":23},"So Hyun Lee, MS","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},"CONTACT","+82-2-2626-1611","pharm23@kumc.or.kr",{"name":30,"role":26,"phone":31,"phoneExt":19,"email":32},"Kyungim Kim, Ph.D.","+82-44-860-1624","kim_ki@korea.ac.kr",[34],{"facility":5,"status":35,"city":36,"state":36,"zip":37,"country":38,"countryCode":19,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Seoul","08308","South Korea",{"type":40,"coordinates":41},"Point",[42,43],126.9784,37.566,{"lat":43,"lon":42},[46,47,48,51,53,55,57,59],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"name":22,"role":23,"phone":19,"phoneExt":19,"email":19},{"name":49,"role":50,"phone":19,"phoneExt":19,"email":19},"Boyoung Kim, MS","SUB_INVESTIGATOR",{"name":52,"role":50,"phone":19,"phoneExt":19,"email":19},"Myounglae Kim, BS",{"name":54,"role":50,"phone":19,"phoneExt":19,"email":19},"Seolhee Jeon, BS",{"name":56,"role":50,"phone":19,"phoneExt":19,"email":19},"Chung-hun Lee, MD",{"name":58,"role":50,"phone":19,"phoneExt":19,"email":19},"Joon-shik Yoon, MD",{"name":30,"role":50,"phone":19,"phoneExt":19,"email":19},{"type":23,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Lee, So Hyun","Chief of Pharmacy Department",[64,67],{"name":65,"class":66},"Korea Hospital Pharmaceutical Education & Research Center","UNKNOWN",{"name":68,"class":6},"Korea University","100600819","evaluation-of-an-opioid-stewardship-program-in-non-cancer-patients-100600819",false,"NCT07102446","Evaluation of an Opioid Stewardship Program in Non-Cancer Patients","Inclusion Criteria:\n\n* Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \\& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025)\n* Adults aged ≥19 years and \\\u003C80 years\n* Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose\n\nExclusion Criteria:\n\n* Patients with active cancer\n* Patients diagnosed with sickle cell disease\n* Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE'\n* Pregnant patients\n* Patients who were prescribed opioid analgesics within the past month for postoperative pain management\n* Patients who were prescribed opioid analgesics within the past month for newly developed pain\n* Patients with communication difficulties\n* Patients who were prescribed buprenorphine for the treatment of opioid use disorder\n* Patients who are deemed inappropriate for study participation at the discretion of the investigator","ALL","19 Years","79 Years",{"count":79,"type":80},70,"ESTIMATED","INTERVENTIONAL",[83],"NA","The objective of this prospective, non-randomized clinical trial is to evaluate the effectiveness of a pharmacist-led Opioid Stewardship Program (OSP) in outpatient adults with chronic non-cancer pain. This study compared OSP implementation with a historical control to determine whether it reduces the incidence of high-risk opioid prescribing and improves patients' awareness, knowledge, and attitudes about opioid use.",[86,87,88,89],"Pain","Chronic Pain","Opioid Analgesia","Opioid Use",[91,92,93,94],"Pharmacist","Pain Management","Opioid Stewardship","Non-Cancer Pain","2025-07-28",{"date":97,"type":98},"2025-08-03","ACTUAL",{"date":100,"type":98},"2025-06-27",{"date":102,"type":80},"2026-06",{"name":5,"class":6},1]